Hydrochloric Acid

Hydrochloric Acid

SCHEMBL440811

C=CC(NCCC[Si](OC)(OC)OCCCN)c1ccccc1.Cl

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SCN8A known ✓ Q9UQD0 1/20 0.30
HTR2A known ✓ P28223 1/20 0.30
HRH1 known ✓ P35367 1/20 0.30
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL336305 0.99 ALDH1A1 (0.34) ALDH1A1SCN8AHTR2AHRH1
Hydrochloric Acid SCHEMBL30673344 0.88 ALDH1A1 (0.36) ALDH1A1
Hydrochloric Acid SCHEMBL30038337 0.87 ALDH1A1 (0.35) ALDH1A1HTTSCN8A
Hydrochloric Acid SCHEMBL22362253 0.87 ALDH1A1 (0.40) ALDH1A1HTTSCN8AHTR2AHRH1
SCHEMBL28997494 0.87 ALDH1A1 (0.34) ALDH1A1SCN8AHTR2AHRH1
SCHEMBL29035494 0.86 ALDH1A1 (0.33) ALDH1A1SCN8A
SCHEMBL1453093 0.86 ALDH1A1 (0.38) ALDH1A1SCN8AHTR2AHRH1
Hydrochloric Acid SCHEMBL31016536 0.85 ALDH1A1 (0.51) ALDH1A1HTTSCN8AHTR2AHRH1
SCHEMBL28850578 0.81 GAA (0.38) ALDH1A1
Hydrochloric Acid SCHEMBL1475959 0.80 ALDH1A1 (0.34) ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1011 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260106321-A1 SEPARATOR FOR ELECTROCHEMICAL DEVICE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME LG ENERGY SOLUTION, LTD. (KR) 2026-04-16 US claimed
US-20250154325-A1 VANILLIC ACID-BASED ORGANIC-INORGANIC COMPOUND, CURABLE COMPOSITION, AND PRODUCTION METHOD THEREOF ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) 2025-05-15 US claimed
US-12107198-B2 Barrier film and method for manufacturing the same, wavelength conversion sheet and method for manufacturing the same, and optical laminate and method for manufacturing the same TOPPAN PRINTING CO., LTD. (JP) 2024-10-01 US claimed
WO-2024196181-A1 SOLID LIPID PARTICLE COMPRISING CONJUGATE OF PURE VITAMIN C AND CATIONIC METAL-AMINO CLAY AND METHOD FOR PREPARING SAME 가천대학교 산학협력단 2024-09-26 WO claimed
CN-117186407-A Organic-inorganic composite, method for preparing the same, and curable composition comprising the same 韩国电子通信研究院 2023-12-08 CN claimed
US-20230391956-A1 SILYL ETHER ISOHEXIDE-BASED ORGANIC-INORGANIC COMPOUND, METHOD FOR PREPARING THE SAME, AND CURABLE COMPOSITION CONTAINING THE SAME ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) 2023-12-07 US claimed
WO-2023096046-A1 POLYPROPYLENE RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MOLDED PRODUCTS COMPRISING SAME 주식회사 코프라 2023-06-01 WO claimed
US-11655118-B2 Film roll and film bundle TOYOBO CO., LTD. (JP) 2023-05-23 US claimed
EP-3775023-B1 A POLYAMIDE COMPOSITION, MANUFACTURING METHOD, AN APPLICATION AND ARTICLE THEREOF BASF SE (DE) 2023-05-10 EP claimed
EP-4094750-A2 ORGANIC-INORGANIC COMPOSITE POWDER AND COMPOSITION INCLUDING THE SAME Amorepacific Corporation (KR) 2022-11-30 EP claimed
US-10301450-B2 Tire BRIDGESTONE CORPORATION (JP) 2019-05-28 US claimed
US-20180371187-A1 BASALT-FIBER-REINFORCED THERMOPLASTIC COMPOSITE MATERIAL AND METHOD OF MANUFACTURING THE SAME HYUNDAI MOTOR COMPANY (KR) 2018-12-27 US claimed
US-20170313847-A1 TIRE BRIDGESTONE CORPORATION (JP) 2017-11-02 US claimed
US-8406663-B2 Developing roller for electrophotographic image forming apparatus, and manufacturing method of the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-03-26 US claimed
US-20120061659-A1 ORGANIC PHOTOELECTRIC CONVERSION ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-15 US claimed
US-20110110690-A1 DEVELOPING ROLLER FOR ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS, AND MANUFACTURING METHOD OF THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2011-05-12 US claimed
US-20100272991-A1 CHROME-FREE COATING COMPOSITIONS FOR SURFACE-TREATING STEEL SHEET INCLUDING CARBON NANOTUBE, METHODS FOR SURFACE-TREATING STEEL SHEET AND SURFACE-TREATED STEEL SHEETS USING THE SAME POSCO (KR) 2010-10-28 US claimed
EP-2240627-A2 CHROME-FREE COATING COMPOSITIONS FOR SURFACE-TREATING STEEL SHEET INCLUDING CARBON NANOTUBE, METHODS FOR SURFACE-TREATING STEEL SHEET AND SURFACE-TREATED STEEL SHEETS USING THE SAME Posco (KR) 2010-10-20 EP claimed
US-20100116179-A1 Polyurethane composite matrix material and composite thereof ADVANCED BUILDING COMPOSITES, LLC 2010-05-13 US claimed
WO-2009084849-A2 CHROME-FREE COATING COMPOSITIONS FOR SURFACE-TREATING STEEL SHEET INCLUDING CARBON NANOTUBE, METHODS FOR SURFACE-TREATING STEEL SHEET AND SURFACE-TREATED STEEL SHEETS USING THE SAME POSCO (KR) 2009-07-09 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260106321-A1 SEPARATOR FOR ELECTROCHEMICAL DEVICE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME ZW10, ILK, PIEZO1 SCN8A 150/4885HTR2A 3561/4885HRH1 4604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.